Design, Synthesis, and Biological Evaluation of Naphthoquinone Salts as Anticancer Agents

The Warburg effect, a unique glycolytic phenomenon in cancer cells, presents a promising target for developing selective anticancer agents. Previously, <b>BH10</b>, a hit compound disrupting glycolytic metabolism, was identified via phenotypic screening, with Kelch-like ECH-associated protein 1 (Keap1) proposed as a potential target. To enhance its potency and selectivity, a library of <b>BH10</b>-derived salt compounds was synthesized. Among these, <b>7b</b> exhibited nanomolar anticancer activity (IC<sub>50</sub> = 22.97 nM) and a high selectivity ratio (IC<sub>50</sub> of non-cancerous cells/IC<sub>50</sub> of cancer cells = 41.43). Molecular docking revealed that all naphthoimidazole salt analogues (<b>7a</b>-<b>f</b>) bind to Keap1 via carbonyl-mediated interactions, with variations in hydrogen-bonding residues (e.g., VAL606, ILE559).

Authors

Institutions

Publication Details

Journal
Molecules
Published
2025-04-27
DOI
https://doi.org/10.3390/molecules30091938
Citations
3
Primary Topic
Bioactive Compounds and Antitumor Agents
Type
article
Field-Weighted Citation Impact
3.92

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Design, Synthesis, and Biological Evaluation of Naphthoquinone Salts as Anticancer Agents

Kyle L. Hoehn, Yao Cheng, Frances L. Byrne, David StC. Black et al.
3 citations
Molecules
Bioactive Compounds and Antitumor Agents
3.92
article

Design, Synthesis, and Biological Evaluation of Naphthoquinone Salts as Anticancer Agents

Kyle L. Hoehn, Yao Cheng, Frances L. Byrne, David StC. Black, Tsz Tin Yu, Ellen M. Olzomer, Naresh Kumar
article en
3 citations

Abstract

The Warburg effect, a unique glycolytic phenomenon in cancer cells, presents a promising target for developing selective anticancer agents. Previously, <b>BH10</b>, a hit compound disrupting glycolytic metabolism, was identified via phenotypic screening, with Kelch-like ECH-associated protein 1 (Keap1) proposed as a potential target. To enhance its potency and selectivity, a library of <b>BH10</b>-derived salt compounds was synthesized. Among these, <b>7b</b> exhibited nanomolar anticancer activity (IC<sub>50</sub> = 22.97 nM) and a high selectivity ratio (IC<sub>50</sub> of non-cancerous cells/IC<sub>50</sub> of cancer cells = 41.43). Molecular docking revealed that all naphthoimidazole salt analogues (<b>7a</b>-<b>f</b>) bind to Keap1 via carbonyl-mediated interactions, with variations in hydrogen-bonding residues (e.g., VAL606, ILE559).

MoleculesVol. 30(9)
UNSW Sydney (AU)
Cancer Institute NSW
Openalex Percentile: Top 8%
Bioactive Compounds and Antitumor Agents
3.92
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.